Rutgers University Researchers Develop PCR-Based SARS-CoV-2 Assay to Detect All Known Variants
The test uses "sloppy molecular beacons" that melt off at different temperatures to determine the specific variant.
Theralink Partners With George Mason, Rutgers Cancer Institute on Breast Cancer Test
The test, developed at George Mason, measures HER2 activation in a breast cancer biopsy to help determine if a patient will respond to treatment.
E. Coli Metabolic Gene Mutations Implicated in Antibiotic Resistance
The mutations in these underappreciated noncanonical genes were overrepresented in the E. coli genomes, indicating they were clinically relevant.
Inflammatory Bowel Disease Genetic Risk Architecture Appears Distinct in African Americans
Using whole-genome sequence data for thousands of African American individuals, researchers teased out ancestry effects on polygenic risk of the conditions.
Jul 29, 2020
Apr 29, 2020
Feb 21, 2020
Nov 29, 2018